Auswahl der wissenschaftlichen Literatur zum Thema „Il-33 vih“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Il-33 vih" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Il-33 vih"
S, Traoré. „Survie des personnes vivant avec le VIH et le Sida suivies dans les 17 sites de traitement antirétroviral au Mali“. Mali Santé Publique 10, Nr. 02 (20.04.2021): 44–49. http://dx.doi.org/10.53318/msp.v10i02.1796.
Der volle Inhalt der QuelleKeita, BB, und Et Al. „Facteurs associés au décès des personnes infectées par le virus de l’immunodéficience humaine sous traitement antirétroviral au Centre Walé de Ségou, Mali.“ Revue Malienne d'Infectiologie et de Microbiologie 18, Nr. 2 (08.01.2024): 38–49. http://dx.doi.org/10.53597/remim.v18i2.2733.
Der volle Inhalt der QuelleAbdourahimi, D., D. Yehadji, E. Briskin, E. M. Khine, C. Arias, K. S. André, F. K. Mukebela et al. „Facteurs associés à la létalité chez les patients hospitalisés pour le VIH avancé“. Public Health Action 13, Nr. 2 (01.08.2023): 19–24. http://dx.doi.org/10.5588/pha.23.0009.
Der volle Inhalt der QuelleBeye, SA, und Et Al. „Prévalence des infections nosocomiales au Centre Hospitalier Universitaire du Point G de Bamako, Mali.“ Revue Malienne d'Infectiologie et de Microbiologie 19, Nr. 1 (13.03.2024): 45–49. http://dx.doi.org/10.53597/remim.v19i1.2794.
Der volle Inhalt der QuelleUsman, S. O., O. M. Ajayi, O. Ebiekura, N. Egbonrelu, G. Ebhojie und A. O. Ariyo. „Evidence of virological failure in patients on second-line anti-retroviral therapy in Southwestern Nigeria: An indication for HIV drug resistance testing“. African Journal of Clinical and Experimental Microbiology 22, Nr. 3 (02.07.2021): 415–19. http://dx.doi.org/10.4314/ajcem.v22i3.13.
Der volle Inhalt der QuelleMathias, Clinton B., Jeffrey Rovatti und Stephanie Polukort. „IL-10 enhances IgE-independent IL-33-mediated mast cell cytokine production“. Journal of Immunology 198, Nr. 1_Supplement (01.05.2017): 145.8. http://dx.doi.org/10.4049/jimmunol.198.supp.145.8.
Der volle Inhalt der QuelleMiller, Ashley M., Damo Xu, Darren L. Asquith, Laura Denby, Yubin Li, Naveed Sattar, Andrew H. Baker, Iain B. McInnes und Foo Y. Liew. „IL-33 reduces the development of atherosclerosis“. Journal of Experimental Medicine 205, Nr. 2 (11.02.2008): 339–46. http://dx.doi.org/10.1084/jem.20071868.
Der volle Inhalt der QuellePark, Su-Ho, Myun Soo Kim, Hui Xuan Lim, Daeho Cho und Tae Sung Kim. „IL-33-matured dendritic cells promote Th17 cell responses via IL-1β and IL-6“. Cytokine 99 (November 2017): 106–13. http://dx.doi.org/10.1016/j.cyto.2017.07.022.
Der volle Inhalt der QuelleNagashima, Ryuichi, Hiroki Ishikawa, Yoshihiro Kuno, Chikara Kohda und Masayuki Iyoda. „IL-33 attenuates renal fibrosis via group2 innate lymphoid cells“. Cytokine 157 (September 2022): 155963. http://dx.doi.org/10.1016/j.cyto.2022.155963.
Der volle Inhalt der QuelleWang, J. X., S. Kaieda, S. Ameri, N. Fishgal, D. Dwyer, A. Dellinger, C. L. Kepley, M. F. Gurish und P. A. Nigrovic. „IL-33/ST2 axis promotes mast cell survival via BCLXL“. Proceedings of the National Academy of Sciences 111, Nr. 28 (30.06.2014): 10281–86. http://dx.doi.org/10.1073/pnas.1404182111.
Der volle Inhalt der QuelleDissertationen zum Thema "Il-33 vih"
Tariq, Mubashira. „IL-33/ST2 and tissue Treg/AREG pathways in the pathophysiology of HIV infection“. Electronic Thesis or Diss., Paris 12, 2021. http://www.theses.fr/2021PA120017.
Der volle Inhalt der QuelleHIV has transformed into a chronic disease, since the advent of ART. There is persistence of immune activation and inflammation. It leads to a severe and massive CD4+T cell depletion, particularly in the gut associated lymphoid tissue (GALT). In addition, persistent inflammation exacerbates tissue damage, particularly in the GI tract. Epithelial barrier damage is a prerequisite for leaky gut and microbial translocation, contributing to persistent immune activation in individuals with chronic HIV infection. This is a potential mechanism of impaired CD4 reconstitution by contributing to fibrosis. Moreover, persistent antigen exposure, negative co-stimulation and chronic inflammation despite ART induced viral suppression, leads to CD8 T cell dysfunction.sST2, a decoy receptor of the alarmin, IL-33, is reported to be a significant predictor of all-cause mortality in HIV patients on HAART. IL-33, previously known as a driver of Th2 immune responses, is now recognized as a switch-hitting cytokine adjuvant. Released from damaged cells, it promotes tissue homeostasis and repair. IL-33 functions to restore gut mucosal integrity following viral- or commensals- induced epithelial damage. It enhances Th1 immune responses attempting to eliminate the pathogens, followed by ILCs- and tissue Tregs- induced repair. IL-33 induces protective immunity against viral infections by boosting CD8+ T cell response. IL-33 induced tissue Tregs play a role in tissue repair mediated by the release of Amphiregulin, an EGF-like growth factor.In this thesis, we assessed the involvement of the IL-33/ST2 axis in epithelial tissue repair and its role on CD8+ T cell function. In a first study, we analyzed whether the persistence of gut damage might be explained by the dysregulated tissue repair involving IL-33/ST2 and tissue Treg/Amphiregulin pathways. In a second study, we aimed to characterize CD8 T cells expressing ST2 and to assess the role of IL-33 on HIV specific CD8 T response.Investigations were carried out on mucosal and blood samples from HIV infected patients on c-ART and seronegative healthy controls. Plasma sST2 levels were elevated. IL-33 mRNA and protein expressions revealed elevated expression in the gut mucosa of HIV patients, whereas it was undetectable in the plasma. IL-33 was associated with increased fibrosis and immune activation while decreased CD4 restoration. Phenotypic and functional characterization of tissue Tregs revealed two distinct subsets. ST2+ Tregs were upregulated in the LPL of HIV infected patients and identified as the source of AREG-producing Tregs. However, we observed a functional defect of these cells with a decrease of AREG-producing Tregs in the HIV LPL. Overall, these results suggest that the profound defect of AREG production by Tregs may contribute to the persistence of gut barrier dysfunction despite ART in HIV infected patients.Phenotypic and functional characterization of ST2 expressing CD8 T cells in the PBMCs, deciphered this subset to be a cytotoxic population of effector (RA+ CCR7-) CD8 T cells, with a high capacity to proliferate with TCR stimulation. Their characterization did not differ between HIV infected and healthy controls. CD8 T cells from blood of HIV infected patients on c-ART were shown to maintain a high expression of ST2 compared to healthy donors. These cells were negatively associated with sST2 levels in the plasma. We observed that, after 5 days of culture with IL-33, GAG- and CEF specific CD8 T cells displayed more cytolytic and non-cytolytic responses with an increased concentration of IFNg, Granzyme A, Granzyme B and sFAS-Lin the culture supernatant.To summarize, our results highlight the dual role of IL-33 in chronic HIV infection: i) a deleterious one contributing to fibrosis in the gut of HIV infection and ii) a positive one enhancing GAG- and CEF specific responses in HIV infected patients on c-ART, indicating its potential as an immunoadjuvant for enhancing vaccine responses
Michaudel, Chloé. „Pollution à l'ozone : maintien de la barrière pulmonaire via l'IL-33, implication des autres membres de la famille IL-1 et régulation cytokinique via AhR“. Thesis, Orléans, 2017. http://www.theses.fr/2017ORLE2040.
Der volle Inhalt der QuelleOzone is a common ambient air polluant. Ozone peaks induce increase of asthma exacerbation, respiratory distress, emergencies and hospital admissions. The aim of this thesis project is to dissect inflammatory mechanisms induced after ozone exposure. This study is conducted according three axes, the first two dealing with the roles of two alarmines, IL-1α and IL-33 and the third is focused on the role of aryl hydrocarbon receptor (AhR), a receptor involved in several pollutant responses. Acute and chronic experimental models of ozone exposure were used to evaluate inflammatory parameters in lung, tissue damage and airway hyperresponsiveness. Here we show that acute ozone exposure induces IL-1α and IL-33 release. IL-33 acts on lung epithelial barrier, allowing the expression and maintenance of tight junctions induced after ozone exposure. Moreover, IL-33 represses neutrophils infiltration while IL-1α induces it. Furthermore we show that AhR is activated after chronic ozone exposure. AhR regulates cytokines production such as IL-17A and IL-22 and plays a protective role against higher inflammation. Overall, IL-33 production and AhR activation are necessary to control ozone-induced inflammation, in contrast to IL-1α. These findings highlight potential therapeutic targets for the treatment of lung inflammation following ozone exposure
Arima, Hiroshi. „B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T cell responses via IL-33“. Kyoto University, 2019. http://hdl.handle.net/2433/236612.
Der volle Inhalt der QuelleBuchteile zum Thema "Il-33 vih"
Cannizzaro, Francesco. „Gli errores (meta)letterari del Meandro da Augusto ai Flavi“. In Studi e ricerche del Dipartimento di Lettere e Filosofia, 155–75. Firenze: Società Editrice Fiorentina, 2024. http://dx.doi.org/10.35948/dilef/978-88-6032-734-5.11.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Il-33 vih"
Kearley, J., TJ Burwell, E. Benjamin, AT Kozhich, N. Donacki, PA Kiener, NA Molfino, R. Kolbeck, AJ Coyle und AA Humbles. „IL-33 Induces Airway Hyperresponsiveness and Alternative Macrophage Activation Via an IL-13 Dependent Mechanism.“ In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2254.
Der volle Inhalt der QuelleDienger, Krista M., DeBroski Herbert, Rena Rani, Amanda Roloson, Evelyn A. Curt-Jones, Timothy Wang und Marsha Wills-Karp. „Trefoil Factor 2 Mediates IL-13-Induced Allergic Asthma Via IL-33 Specific Th2 Initiation“. In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4270.
Der volle Inhalt der QuelleUpham, John, Lisa Jurak und Yang Xi. „IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor“. In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa567.
Der volle Inhalt der QuelleMaruoka, S., S. Yamada, R. Ito, S. Nunomura, S. Toyoshima, Y. Okayama, K. Izuhara, S. Hashimoto und Y. Gon. „A Humanized Mouse Model to Study Asthmatic Airway Inflammation Via Human IL-33/IL-13 Axis“. In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2902.
Der volle Inhalt der QuelleScott, I. C., E. England, D. G. Rees, T. Erngren, C. Chaillan Huntington, K. F. Houslay, D. A. Sims et al. „Tozorakimab: a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction“. In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2467.
Der volle Inhalt der QuelleSperling, Anne I., Bryan S. Clay, Jesse Williams, Tiara Byrd und Melissa Y. Tjota. „Dendritic Cells Produce IL-33 When Stimulated Via FcgR And TLR-4“. In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4271.
Der volle Inhalt der QuelleStrickson, S., K. F. Houslay, V. A. Negri, Y. Ohne, T. Ottosson, R. B. Dodd, C. Chaillan Huntington et al. „Oxidised IL-33 signals via RAGE/EGFR to drive a COPD-associated phenotype“. In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2482.
Der volle Inhalt der QuelleMan, L. H. „IL-33/ST2 Regulates Tissue Remodeling Via MAPK and NF-κB Pathways in Nasal Polyp“. In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7177.
Der volle Inhalt der QuelleDraijer, Christina, Machteld N. Hylkema, Catherine M. Greene, Pieter A. Klok, Wim Timens, Dirkje S. Postma und Barbro N. Melgert. „Estrogen Protects Against Airway Inflammation Via Upregulation Of Secretory Leukoprotease Inhibitor And Downregulation Of IL-33“. In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6483.
Der volle Inhalt der QuelleRamu, Sangeetha, Jenny Calvén, Mandy Menzel, Hamid Akbarshahi, Cecilia Andersson, Charalambos Michaeloudes, Fan Chung und Lena Uller. „Rhinovirus-induced IL-33 is overexpressed in asthmatic bronchial smooth muscle cells via TLR3 and activation of TAK1“. In Abstracts from the 17th ERS Lung Science Conference: ‘Mechanisms of Acute Exacerbation of Respiratory Disease’. European Respiratory Society, 2019. http://dx.doi.org/10.1183/23120541.lungscienceconference-2019.pp132.
Der volle Inhalt der Quelle